PMD

Psychemedics Corp

No insider bought or sold Psychemedics Corp in the last 12 months

$0Bought, 12 mo

$0Sold, 12 mo

Follow PMD

PMD over the last year

Prices for PMD aren't in yet.

PMD after insider buys

3 months after each buy, from the first price a copier could get.

−2.0%Average

+5.0 ptsVs S&P 500

1 of 3Higher

3 buys since 2022 with 3 months of prices.

Every filing

19 insider filings since 2016, newest first

PMDBuy

Powell Anderson Capital Partners LLC · 10% owner

$305K+35.0%Dec 17

PMDBuy

Powell Anderson Capital Partners LLC · 10% owner

$232K+21.0%Dec 12

PMDBuy

Peter Kamin · Director and 10% owner

$3.3M+218.0%Dec 5

PMDSell

Charles M Doucot · EVP

$59K−35.0%Aug 21

PMDBuy

Peter Kamin · 10% owner

$284K+7.0%Apr 21

PMDBuy

Peter Kamin · 10% owner

$47K+1.0%Apr 11

PMDBuy

Peter Kamin · 10% owner

$86K+1.0%Mar 31

PMDBuy

Peter Kamin · 10% owner

$26K+1.0%Mar 18

PMDSell

Michael I Schaffer · VP of Laboratory Operations

$91K−33.0%Jun 14

PMDSell

Neil Lerner · VP - Finance

$137K−41.0%Mar 13

PMDSell

Michael I Schaffer · VP of Laboratory Operations

$122K−18.0%Sep 10

PMDSell

Neil Lerner · VP - Finance

$98K−18.0%May 23

PMDSell

Michael I Schaffer · VP of Laboratory Operations

$154K−18.0%Sep 6

PMDSell

Michael I Schaffer · VP of Laboratory Operations

$61K−7.0%May 15

PMDSell

James V. Dyke · VP - Sales

$216K−38.0%Mar 13

PMDSell

James V. Dyke · VP - Sales

$116K−16.0%Dec 15

PMDSell

Fred J Weinert · Director

$113K−3.0%Dec 12

PMDSell

Neil Lerner · VP - Finance

$74K−10.0%Nov 21

PMDSell

James V. Dyke · VP - Sales

$236K−23.0%Nov 16

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.